Picture of Allena Pharmaceuticals logo

ALNAQ — Allena Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Allena Pharmaceuticals Reports Q1 Loss Per Share Of $0.55

May 8 (Reuters) - Allena Pharmaceuticals Inc  ALNA.O :
    * ALLENA PHARMACEUTICALS REPORTS FIRST QUARTER 2019
FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
    * Q1 LOSS PER SHARE $0.55
    * Q1 EARNINGS PER SHARE ESTIMATE $-0.49 -- REFINITIV IBES
DATA
    * ALL CLINICAL PROGRAMS PROGRESSING ON TRACK;
    * ALLENA PHARMACEUTICALS-SEES EXISTING CASH & CASH
EQUIVALENTS TO
BE SUFFICIENT TO FUND OPERATING EXPENSES & CAPITAL REQUIREMENTS
THROUGH AT LEAST 1H20

Source text for Eikon:  ID:nGNX83yhRp 
Further company coverage:  ALNA.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Allena Pharmaceuticals

See all news